| YSR | Year Survival Rate |
|---|---|
| CDS | cardiovascular surgery; catechol-3, 5-disulfonate; caudal dysplasia syndrome; Chemical Data System; ... |
| CONSENSUS | Cooperative North Scandinavian Enalapril Survival Study |
| DFS | disease-free survival |
| EFS | electric field stimulation; event-free survival |
| survival rate | The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. (12 Dec 1998) |
|---|---|
| survival time | The period elapsing between the completion or institution of any procedure and death, the life-span of biologically or physically marked erythrocytes or other cells. (05 Mar 2000) |
| disease-free survival | Period after successful treatment in which there is no appearance of the symptoms or effects of the disease. (12 Dec 1998) |
| tissue survival | The span of viability of a tissue or an organ. (12 Dec 1998) |
| five year survival rate | The proportion of patients still alive five years after a diagnosis or form of treatment is completed. Usually applied to statistics of survival of cancer patients, since after five years, recurrences are much less likely to occur. (05 Mar 2000) |
| 5-year relative survival rate | <statistics> The likelihood that a patient will not die from causes associated with his or her cancer for at least 5 years after diagnosis. This is the standard many professionals use when determining someone a survivor of cancer. (16 Dec 1997) |
| long-term survival | <oncology> Term used to describe the survival of leukaemia patients who have been disease free for prolonged periods of time, usually at least five years. The chance of disease returning (relapse) decreases with time. (13 Nov 1997) |